Page last updated: 2024-10-26

dimaprit and Leukemia, Monocytic, Acute

dimaprit has been researched along with Leukemia, Monocytic, Acute in 1 studies

Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.

Leukemia, Monocytic, Acute: An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smit, MJ1
Leurs, R1
Shukrula, SR1
Bast, A1
Timmerman, H1

Other Studies

1 other study available for dimaprit and Leukemia, Monocytic, Acute

ArticleYear
Rapid desensitization of the histamine H2 receptor on the human monocytic cell line U937.
    European journal of pharmacology, 1994, Dec-15, Volume: 288, Issue:1

    Topics: Cells, Cultured; Cyclic AMP; Dimaprit; Dose-Response Relationship, Drug; Histamine; Histamine Agonis

1994